DURECT Corp (DRRX)

• Market cap: $21.7M
• 1 day: -1.88%
• 5 days: -14.63%
• 1 month: -12.50%
• 3 months: -9.21%
• 6 months: -45.74%
• Year to date: -11.48%
• 1 year: -16.31%
• 5 years: -96.32%
• 10 years: -96.46%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.

Employees: 21

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

7,400% more call options, than puts

Call options by funds: $75K | Put options by funds: $1K

18% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 11

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0.93% less ownership

Funds ownership: 22.93% [Q3] → 21.99% (-0.93%) [Q4]

2% less funds holding

Funds holding: 44 [Q3] → 43 (-1) [Q4]

46% less capital invested

Capital invested by funds: $9.52M [Q3] → $5.12M (-$4.4M) [Q4]